LFMD
LifeMD, Inc.
+0.10 (+2.96%)3.31USD178K成交股數159M市值–本益比(近四季)0.8股價營收比-3.5%營收年增(近四季)2026-11-09下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 47.3M-4% | 50.2M-1% | 34.0M-36% | 60.2M+19% | 49.0M+11% | 50.9M+13% | 53.3M+38% | 50.7M+41% | 44.1M | 44.9M | 38.6M | 35.9M |
| 營業成本 | 5.3M | 5.9M | 5.3M | 7.4M | 6.8M | 8.1M | 5.0M | 5.0M | 4.6M | 5.4M | 4.8M | 4.5M |
| 毛利 | 42.0M-0% | 44.2M+3% | 28.6M-41% | 52.8M+16% | 42.2M+7% | 42.8M+8% | 48.3M+43% | 45.6M+45% | 39.5M | 39.5M | 33.8M | 31.4M |
| 毛利率 | 88.8% | 88.2% | 84.3% | 87.7% | 86.0% | 84.0% | 90.6% | 90.1% | 89.6% | 88.1% | 87.6% | 87.3% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 13.6M | 15.2M | 12.6M | 16.6M | 14.4M | 14.3M | 18.1M | 18.5M | 15.3M | 15.6M | 13.4M | 12.1M |
| 營業利益 | −7.1M+204% | −8.9M+656% | −2.2M-46% | −2.0M-69% | −2.3M-62% | −1.2M-46% | −4.0M-13% | −6.3M+29% | −6.2M | −2.2M | −4.6M | −4.9M |
| 營業利益率 | -15.1% | -17.8% | -6.4% | -3.3% | -4.8% | -2.3% | -7.5% | -12.4% | -14.0% | -4.8% | -11.8% | -13.6% |
| 稅後淨利 | −7.1M+337% | −8.9M+4728% | −5.6M+21% | −3.8M-45% | −1.6M-76% | −184K-101% | −4.7M-24% | −6.9M+2% | −6.8M | 34.7M | −6.1M | −6.7M |
| 淨利率 | -15.0% | -17.7% | -16.6% | -6.3% | -3.3% | -0.4% | -8.7% | -13.6% | -15.3% | 77.4% | -15.9% | -18.7% |
| 稀釋 EPS | -0.16+220% | -0.20+900% | – | – | -0.05 | -0.02 | -0.13 | – | – | – | – | – |
| 稀釋股數 | 47.8M | 47.3M | 45.1M | 46.2M | 44.4M | 43.1M | 42.0M | 41.3M | 39.2M | 33.9M | 34.5M | 32.6M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 25.1M | 34.5M | 36.8M | – | 36.2M | 34.4M | 37.6M | 35.7M | 35.1M | 33.1M | 15.3M | 11.9M |
| 應收帳款 | 11.3M | 9.9M | 9.3M | 9.2M | 7.3M | 10.2M | 6.0M | 5.7M | 5.3M | 6.3M | 4.4M | 3.7M |
| 存貨 | 3.0M | 3.2M | 2.8M | 3.4M | 3.3M | 3.0M | 2.6M | 2.1M | 2.4M | 2.8M | 3.8M | 3.7M |
| 總資產 | 59.9M | 70.1M | 70.4M | 66.0M | 73.6M | 73.6M | 72.6M | 63.8M | 61.5M | 58.5M | 40.7M | 35.4M |
| 有息負債 | – | – | – | – | 15.9M | – | – | – | – | – | – | – |
| 總負債 | 51.9M | 55.1M | 47.3M | 62.6M | 73.2M | 74.0M | 78.5M | 65.9M | 60.2M | 52.9M | 51.8M | 45.7M |
| 股東權益 | 8.0M | 15.0M | 23.2M | 1.3M | −1.8M | −2.3M | −7.7M | −4.2M | −845K | 3.5M | −12.7M | −16.0M |
| 負債比 | 86.7% | 78.6% | 67.1% | 94.9% | 99.5% | 100.5% | 108.2% | 103.2% | 97.9% | 90.5% | 127.2% | 128.8% |
| 淨現金(現金 − 有息負債) | – | – | – | – | 20.3M | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 445K-86% | – | – | – | 3.1M | – | – | 5.2M | – | – | – |
| 資本支出 | – | 105K | – | – | – | 118K | – | – | 176K | – | – | – |
| 自由現金流 | – | 339K-88% | – | – | – | 3.0M | – | – | 5.0M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | 270K | – | – | – | – | – | – | – | – |
| 現金股利 | – | 777K | – | – | – | 777K | – | – | 777K | – | – | – |
| 自由現金流率 | – | 0.7% | – | – | – | 5.8% | – | – | 11.4% | – | – | – |
營收拆解 2024 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2024 年度 · 287M
| Telehealth | 158M | 55.1% | +78.2% |
|---|---|---|---|
| Telehealth Subscription Revenue | 70.0M | 24.4% | +1541.1% |
| Work Simpli | 54.0M | 18.8% | -0.7% |
| Medifast Collaboration Revenue | 5.0M | 1.7% | 0.0% |
產品／服務2024 年度 · 209M
| Telehealth Revenue | 155M | 74.1% | +57.7% |
|---|---|---|---|
| Work Simpli Revenue | 54.0M | 25.9% | -0.7% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 194M | +25.3% | −11.2M | -5.8% | 0.25 | 6.4M |
| FY2024 | 155M | +1.5% | 24.5M | 15.8% | -0.60 | 16.0M |
| FY2023 | 153M | +28.2% | 17.8M | 11.7% | – | 8.6M |
| FY2022 | 119M | +28.2% | −45.5M | -38.3% | – | −23.3M |
| FY2021 | 92.9M | +149.0% | −60.9M | -65.6% | – | −33.3M |
| FY2020 | 37.3M | +199.1% | −58.6M | -157.3% | – | – |
| FY2019 | 12.5M | +29227.5% | −3.1M | -25.2% | – | – |
| FY2018 | 43K | – | −1.2M | -2,918.6% | – | – |